tiprankstipranks
RepliCel Life Sciences Inc (TSE:RP)
:RP
Canadian Market

RepliCel Life Sciences (RP) Income Statement

Compare
4 Followers

RepliCel Life Sciences Income Statement

Last quarter (Q2 2024), RepliCel Life Sciences's total revenue was C$88.43K, a decrease of 0.00% from the same quarter last year. In Q2, RepliCel Life Sciences's net income was C$-187.94K. See RepliCel Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74K
Gross Profit
C$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74KC$ 353.74K
Operating Expenses
C$ 1.74MC$ 1.75MC$ 2.65MC$ 1.68MC$ 3.28M
Depreciation and Amortization
C$ 1.47KC$ 839.00C$ 1.15KC$ 1.57KC$ 2.17K
EBITDA
C$ -1.38MC$ -664.49KC$ -3.93MC$ -1.51MC$ -2.97M
Operating Income
C$ -1.39MC$ -191.44KC$ -3.17MC$ -1.14MC$ -2.88M
Other Income/Expenses
C$ 1.07MC$ 652.28KC$ -1.77MC$ -229.91KC$ -77.32K
Pretax Income
C$ -311.73KC$ -743.23KC$ -4.07MC$ -1.58MC$ -3.00M
Net Income
C$ -311.73KC$ -743.23KC$ -4.07MC$ -1.58MC$ -3.00M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.01C$ -0.02C$ -0.13C$ -0.06C$ -0.12
Diluted EPS
C$ -0.01C$ -0.02C$ -0.13C$ -0.06C$ -0.12
Weighted Average Shares Outstanding
59.24M 37.77M 32.49M 26.96M 24.11M
Weighted Average Shares Outstanding (Diluted)
59.24M 37.77M 32.49M 26.96M 24.11M
Currency in CAD

RepliCel Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis